Skip to content
HowShorted

PTC Therapeutics, Inc. short interest in 2021

In 2021, PTC Therapeutics, Inc.'s disclosed short interest ran from 6.16% of shares outstanding on 15 Jan 2021 to 9.70% on 31 Dec 2021, a change of +3.54 percentage points. The year's high was 9.77% on 15 Dec 2021 and its low 5.88% on 12 Feb 2021, averaging 7.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.14 days on 15 Nov 2021. Full history: PTC Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PTC Therapeutics, Inc. in 2021

2021 in figures

Start of year
6.16% (15 Jan 2021)
End of year
9.70% (31 Dec 2021)
Change
+3.54 pp
High
9.77% (15 Dec 2021)
Low
5.88% (12 Feb 2021)
Average
7.32%
Highest days to cover
17.14 (15 Nov 2021)
SEC filings marked
9

Every report in 2021

PTC Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20216.16%9.36results (8-K)
29 Jan 20216.00%9.23
12 Feb 20215.88%7.99
26 Feb 20216.99%10.5210-K filed, results (8-K)
15 Mar 20217.49%10.16
31 Mar 20217.65%8.87
15 Apr 20217.70%14.18
30 Apr 20217.65%8.81
14 May 20217.21%6.9710-Q filed, results (8-K)
28 May 20216.75%11.99
15 Jun 20216.83%11.76
30 Jun 20216.85%9.74
15 Jul 20217.18%15.68
30 Jul 20217.54%13.0610-Q filed, results (8-K)
13 Aug 20217.40%16.92
31 Aug 20216.38%9.58
15 Sep 20216.32%14.02
30 Sep 20216.66%7.35
15 Oct 20217.17%14.38
29 Oct 20217.61%9.9010-Q filed, results (8-K)
15 Nov 20218.43%17.14
30 Nov 20218.37%7.49
15 Dec 20219.77%13.40
31 Dec 20219.70%12.87

See also: PTC Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.